So Whats Wrong with Whole Genome Sequencing?
Whole genome sequencing is the process of determining the entirety, or nearly the entirety, of theDNAsequence of an organism'sgenome. It has been offered to determine an individuals risk of future disease based on a subjects DNA mismatch from normal. However, other than relatively rare monogenic diseases (caused by one gene), most illnesses and traits result from multiple gene interactions coupled with environmental and lifestyle.
Accuracy or Tea Leaf Reading?
Whole genome sequencing might prove useful to someone already sick to concoct an individualized precision-medicine cocktail. But for predicting future disease, based on the available data we now have, its validity is akin to reading tea leaves.
Even if the interplay of environmental, lifestyleand multiple genetic variables could be addressed, all this data can do is project a population -- not individual -- risk of disease. Thats the first problem with extrapolating the new knowledge, its not precise. But there is more.
The extent of ethnic influences on genetic expression is not yet known. Whole genome sequencing data has focused on white Europeans, constraining extrapolation to other ethnicities. Recently, 100,000 whole genome sequences, half from African-Americans, Hispanic, or Asian, have been sequenced, supposedly making the database more relevant to the non-white population. But much of the data is only available to researchers associated with certain American universities. Exactly how much of the 50% of the data collected belongs to which of the subgroups is not readily known, rendering reliance by non-whites risky.
The Death of Privacy
Some enthusiasts ignore the accuracy concerns and call for the creation of a national DNA database where we would assemble the whole genome package of all our citizens. the next step in Pandoras progress. The British have been planning (plotting?) this since 2013. This whole genome sequence data supposedly would be anonymized (but the anonymization would be reversible and simple to untangle). Its use is proposed to be available to private companies, including Google, without peoples knowledge and consent. Suffice it to say, the abuses, including privacy violations, are rather horrific to contemplate.
Genomed at Birth
Compiling whole-scale genomic information for a willing and consenting adult might fall under the realm of autonomy, although the cost for such testing would create its own disparities and social justice concerns. Engaging in the same practice for newborns, as proposed by the British Newborn Genomes Programing project, poses its own problems. While the information could disclose risks of hundreds of conditions, some are without cure or preventive measures. That knowledge might well be considered a burden not a blessing.
In the US, some 29 diseases are routinely screened for at birth. But these are diseases where early diagnosis and treatment are available, increasing the chances of healthy development and reducing death. Many such screens are mandatory, although some opt-outs do exist.
Using whole genome sequencing to achieve this end would disclose diseases, both with treatment or preventatives and those without. Of what use would the latter of knowledge be?
Consider the discussion of Huntingtons Chorea by my colleague, Dr. Dinerstein, disclosing that most adults wouldnt even avail themselves of knowing they would have a disease without cure or treatment or preventive measures even if it were available.
Can We Handle the Knowledge?
Another objection is, do we have the person-power to address findings that might be treatable? At recent conferences discussing the issue, objections were voiced by the healthcare industry, which anticipates an overflow of conditions without sufficient personnel to treat them, along with questions regarding the training of healthcare workers [and genetic counselors].
And What About the Rights of the Child?
Amongst issues that were not raised were the rights of the child. It is one thing to identify childhood diseases that a parent might be able to prevent. But the Whole Genome Project doesnt limit itself to illness by age knowledge of the panoply of diseases for which a baby is at risk in their future life would be available to the parent and, by extension, the siblings. Perhaps a child, on reaching adulthood, wouldnt want their parent to know they are at risk of depression, Alzheimers, or diabetes? Should that knowledge be made available?
Pre-Implantation Genetic Testing
Pre-implantation Genetic Testing (PGT) is now used to identify monogenetic diseases in newborns testing to determine illness caused by a single gene. It determines which embryos are suitable for implantation. In the UK, its use limited - legal to prevent serious illness.
Genomic Prediction is the creator of LifeView, an advanced genetic testing platform for embryos for IVF. We help couples have the healthiest child possible, protecting your baby from genetic risks that run in your family."
Recently, companies have expanded single-gene tests to encompass a broader range of genes - to assess not just a specific disease but the likelihood of a particular trait. Companies like Genomic Prediction advertise polygenic embryo screening, or PGT-P, to assess genetic data involving multiple genes (although not the whole genome) to predict the healthiest baby. [2] These PGT-P tests evaluate a series of genes arguably related to healthful traits but could be gerry-rigged to select for intelligence, aesthetics, or athleticism in the future.
Genomic Prediction and its competitors use algorithms in their analysis, relying in some cases on adult populations that may not even be relevant. Even if a PGT-P trait was relatively accurate in assessing relative (population) risk of disease, the value in predicting absolute risk (actual risk in individual) is very small. A 50% increased population risk translates into an absolute risk of that trait in an individual of 0.5% - a hundred-fold reduction.
At present there is no evidence that PGT-P can reliably predict the relative risk of an embryo developing a certain trait of disease.
Dr. Francesca Forzano, Consultant in clinical genetics Guy's & St Thomas' NHS Foundation Trust, London
The best the tests can currently do is approximate which embryo is the hardiest and has the least risk forfuture biologic disease at the time of selection. The effects of environmental stressors, including pregnancy, arent included in the analysis giving the would-be parents a false sense of security.
It's not surprising that the European Society of Human Genetics, the European Society of Human and Reproduction Embryology, and the American College of Medical Genetics have released statements advising against using polygenic risk scores for embryo selection. In the UK, its use is illegal.
Solomons Choice
Some bioethicists, like Hank Greeley, oppose the technique, leaving open the possibility of its future use, should they prove more accurate, claiming well-informed parents should be able to make their own decisions.
But the process also determines which embryos are rejected. Even if the testing proves more accurate, its use might be a societal tragedy. Selecting the ostensibly healthiest embryos means the less healthy ones are rejected. Superficially, this might seem beneficial, individually as well as societally. But this process also selects against geniuses such as Stephen Hawking, who suffered AMLS, or schizophrenic Nobel Prize winner John Nash.
Determining the healthiest or best baby to be born might evidence hubris rather than wisdom on the part of he or she doing the selecting.
Future Risk
The problems raised by PGT-P, which confines itself to groups of genes, are magnified by attempts to perform whole-genome sequencing at the embryo stage. These additional tests promise to identify the entire genomic structure of the would-be child before it is even born. Now, instead of selecting the healthiest baby, parents might specify one that is also beautiful and brawny weighting whichever traits they deem most important to them.
Relevant molecular and statistical techniques published last month in Nature Medicine touted a high degree of validity for this technique in predicting genetic risks for adult-onset diseases, including diabetes and breast cancer, when used in an embryo.
Ethical questions that should have been addressed regarding using whole-genome sequencing first in adults and then babies, now raise themselves for embryos.
This applies to privacy rights belonging to the embryo once it is born. Even assuming predictions can be accurately made, fore-knowledge of diseases that may surface in adulthood, like atrial fibrillation, cancer, or dementia, is not something an individual might want their parents, employers, or colleagues to know. And once the knowledge-genie is out of the bottle, its impossible to stuff it back in.
So, we keep trucking along with the technology before fully considering the ethical implications that would be unleashed. And initial thoughts may well change. [3]
Present Risk Ignored: And Virtues of the Old-Fashioned Way
The excitement of the new always seems to eclipse the banalities of the old. Certainly, infertile parents may require IVF, but as the hype around PGT-P increases, fertile would-be parents might be tempted to avail themselves of IVF to enable themselves of the service. That would be unwise.
IVF is associated with
IVF, then, should not be the first choice for conception.
Instead of searching for more knowledge, perhaps we should concentrate on safely using the knowledge we have.
[1] Genesis chapter 2
[2] at least four companies are advertising the service.
[3 Even bioethicist Julian Savelescu, who, as recently as June 2021, advocated a parental obligation of procreative beneficence, requiring selecting the child with the chance of the best life using PRS, changed his tune by October.
Visit link:
The Curse of Knowledge and Whole Genome Sequencing - American Council on Science and Health
- World Health Organization reference values for human semen characteristics [Last Updated On: August 17th, 2024] [Originally Added On: April 6th, 2010]
- Economic consequences of overweight and obesity in infertility: a framework for evaluating the costs and outcomes of fertility care [Last Updated On: August 17th, 2024] [Originally Added On: April 6th, 2010]
- Maternal metabolism and obesity: modifiable determinants of pregnancy outcome [Last Updated On: August 17th, 2024] [Originally Added On: April 6th, 2010]
- Brain imaging studies of appetite in the context of obesity and the menstrual cycle [Last Updated On: August 17th, 2024] [Originally Added On: April 6th, 2010]
- The impact of body mass index on semen parameters and reproductive hormones in human males: a systematic review with meta-analysis [Last Updated On: August 17th, 2024] [Originally Added On: April 6th, 2010]
- Options for fertility preservation in prepubertal boys [Last Updated On: August 17th, 2024] [Originally Added On: April 6th, 2010]
- Xenografting of testicular tissue from an infant human donor results in accelerated testicular maturation [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- Karyotype of miscarriages in relation to maternal weight [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- Endoglandular trophoblast, an alternative route of trophoblast invasion? Analysis with novel confrontation co-culture models [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- Regulation of extravillous trophoblast invasion by uterine natural killer cells is dependent on gestational age [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- Functional regulation of thymic stromal lymphopoietin on proliferation and invasion of trophoblasts in human first-trimester pregnancy [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- Prospective study of the forearm bone mineral density of long-term users of the levonorgestrel-releasing intrauterine system [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- Functional attenuation of human sperm by novel, non-surfactant spermicides: precise targeting of membrane physiology without affecting structure [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- Characteristics indicating adenomyosis coexisting with leiomyomas: a case-control study [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- The risk of post-molar gestational trophoblastic neoplasia is higher in heterozygous than in homozygous complete hydatidiform moles [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- Cumulative ongoing pregnancy rate achieved with oocyte vitrification and cleavage stage transfer without embryo selection in a standard infertility program [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- Pregnancy outcome in female childhood cancer survivors [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- Offering excess oocyte aspiration and vitrification to patients undergoing stimulated artificial insemination cycles can reduce the multiple pregnancy risk and accumulate oocytes for later use [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- Avoidance of weekend oocyte retrievals during GnRH antagonist treatment by simple advancement or delay of hCG administration does not adversely affect IVF live birth outcomes [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- Who should pay for assisted reproductive techniques? Answers from patients, professionals and the general public in Germany [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- Sperm donor limits that control for the 'relative' risk associated with the use of open-identity donors [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- Long-term cryostorage of sperm in a human sperm bank does not damage progressive motility concentration [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- Screening for biomarkers of spermatogonia within the human testis: a whole genome approach [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- Avoiding transgenerational risks of mitochondrial DNA disorders: a morally acceptable reason for sex selection? [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- Cross border reproductive care in six European countries [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- Morphometric dimensions of the human sperm head depend on the staining method used [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- ESX1 gene expression as a robust marker of residual spermatogenesis in azoospermic men [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- Innovative virtual reality measurements for embryonic growth and development [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- Consecutive or non-consecutive recurrent miscarriage: is there any difference in carrier status? [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- A longitudinal study of contraception and pregnancies in the same women followed for a quarter of a century [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- Predictors of bleeding and user satisfaction during consecutive use of the levonorgestrel-releasing intrauterine system [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- Direct proportional relationship between endometrioma size and ovarian parenchyma inadvertently removed during cystectomy, and its implication on the management of enlarged endometriomas [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- Large prospective, pregnancy and infant follow-up trial assures the health of 1000 fetuses conceived after treatment with the GnRH antagonist ganirelix during controlled ovarian stimulation [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- Altered aquaporin expression in women with polycystic ovary syndrome: hyperandrogenism in follicular fluid inhibits aquaporin-9 in granulosa cells through the phosphatidylinositol 3-kinase pathway [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- Fast-release orodispersible tramadol as analgesia in hysterosalpingography with a metal cannula or a balloon catheter [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- Xenotransplantation of cryopreserved human ovarian tissue into murine back muscle [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- Predictors of psychological distress in patients starting IVF treatment: infertility-specific versus general psychological characteristics [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- Psychological adjustment, knowledge and unmet information needs in women undergoing PGD [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- Mothers of IVF and spontaneously conceived twins: a comparison of prenatal maternal expectations, coping resources and maternal stress [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- Psychological well-being and sexarche in women with polycystic ovary syndrome [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- Is human fecundity declining in Western countries? [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis [Last Updated On: August 17th, 2024] [Originally Added On: June 5th, 2010]
- Current achievements and future research directions in ovarian tissue culture, in vitro follicle development and transplantation: implications for fertility preservation [Last Updated On: August 17th, 2024] [Originally Added On: June 5th, 2010]
- Human studies on genetics of the age at natural menopause: a systematic review [Last Updated On: August 17th, 2024] [Originally Added On: June 5th, 2010]
- Beyond oxygen: complex regulation and activity of hypoxia inducible factors in pregnancy [Last Updated On: August 17th, 2024] [Originally Added On: June 5th, 2010]
- Current knowledge of the aetiology of human tubal ectopic pregnancy [Last Updated On: August 17th, 2024] [Originally Added On: June 5th, 2010]
- Economic contraction and birth outcomes: an integrative review [Last Updated On: August 17th, 2024] [Originally Added On: June 5th, 2010]
- Teratogenic mechanisms of medical drugs [Last Updated On: August 17th, 2024] [Originally Added On: June 5th, 2010]
- Levels of semenogelin in human spermatozoa decrease during capacitation: involvement of reactive oxygen species and zinc [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- Apoptosis and meiotic segregation in ejaculated sperm from Robertsonian translocation carrier patients [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- In humans, zona pellucida glycoprotein-1 binds to spermatozoa and induces acrosomal exocytosis [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- Variants of the EPPIN gene affect the risk of idiopathic male infertility in the Han-Chinese population [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- Epidermal clitoral inclusion cysts: not a rare complication of female genital mutilation [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- PCOSMIC: a multi-centre randomized trial in women with PolyCystic Ovary Syndrome evaluating Metformin for Infertility with Clomiphene [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- Single versus double intrauterine insemination in multi-follicular ovarian hyperstimulation cycles: a randomized trial [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- Soluble HLA-G is an independent factor for the prediction of pregnancy outcome after ART: a German multi-centre study [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- Obstetric outcomes after transfer of vitrified blastocysts [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- Occasional involvement of the ovary in Ewing sarcoma [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- Y chromosome microdeletions, sperm DNA fragmentation and sperm oxidative stress as causes of recurrent spontaneous abortion of unknown etiology [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- Development and preliminary validation of the fertility status awareness tool: FertiSTAT [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- Xenotransplantation of human ovarian tissue to nude mice: comparison between four grafting sites [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- Involvement of CFTR in oviductal HCO3- secretion and its effect on soluble adenylate cyclase-dependent early embryo development [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- Effect of endometriosis on the protein expression pattern of follicular fluid from patients submitted to controlled ovarian hyperstimulation for in vitro fertilization [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- Activin A regulates trophoblast cell adhesive properties: implications for implantation failure in women with endometriosis-associated infertility [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- Clinical significance of sperm DNA damage in assisted reproduction outcome [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- Fall in implantation rates following ICSI with sperm with high DNA fragmentation [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- Prevalence of unsuspected uterine cavity abnormalities diagnosed by office hysteroscopy prior to in vitro fertilization [Last Updated On: August 17th, 2024] [Originally Added On: July 21st, 2010]
- Ultra-conservative fertility-sparing strategy for bilateral borderline ovarian tumours: an 11-year follow-up [Last Updated On: August 17th, 2024] [Originally Added On: July 21st, 2010]
- Fertility after autologous ovine uterine-tubal-ovarian transplantation by vascular anastomosis to the external iliac vessels [Last Updated On: August 17th, 2024] [Originally Added On: July 21st, 2010]
- Uterus transplantation in the baboon: methodology and long-term function after auto-transplantation [Last Updated On: August 17th, 2024] [Originally Added On: July 21st, 2010]
- Prestimulation parameters predicting live birth in anovulatory WHO Group II patients undergoing ovulation induction with gonadotrophins [Last Updated On: August 17th, 2024] [Originally Added On: July 21st, 2010]
- Transfer of a selected single blastocyst optimizes the chance of a healthy term baby: a retrospective population based study in Australia 2004-2007 [Last Updated On: August 17th, 2024] [Originally Added On: July 21st, 2010]
- Disclosure patterns of mode of conception among mothers and fathers-5-year follow-up of the Copenhagen Multi-centre Psychosocial Infertility (COMPI) cohort [Last Updated On: August 17th, 2024] [Originally Added On: July 21st, 2010]
- Assisted reproductive technology in Europe, 2006: results generated from European registers by ESHRE [Last Updated On: August 17th, 2024] [Originally Added On: July 21st, 2010]
- A decade of sperm washing: clinical correlates of successful insemination outcome [Last Updated On: August 17th, 2024] [Originally Added On: July 21st, 2010]
- Sperm DNA integrity in cancer patients before and after cytotoxic treatment [Last Updated On: August 17th, 2024] [Originally Added On: July 21st, 2010]
- Speriolin is a novel human and mouse sperm centrosome protein [Last Updated On: August 17th, 2024] [Originally Added On: July 21st, 2010]
- No influence of body mass index on first trimester fetal growth [Last Updated On: August 17th, 2024] [Originally Added On: July 21st, 2010]
- HLA sharing among couples appears unrelated to idiopathic recurrent fetal loss in Saudi Arabia [Last Updated On: August 17th, 2024] [Originally Added On: July 21st, 2010]